↓ Skip to main content

Dove Medical Press

Article Metrics

Treating Lennox–Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide

Overview of attention for article published in Neuropsychiatric Disease and Treatment, September 2010
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent
7 patents

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
15 Mendeley
Title
Treating Lennox–Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide
Published in
Neuropsychiatric Disease and Treatment, September 2010
DOI 10.2147/ndt.s6465
Pubmed ID
Authors

Allison Chung

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 7%
Unknown 14 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 20%
Student > Doctoral Student 2 13%
Other 2 13%
Professor > Associate Professor 2 13%
Student > Master 2 13%
Other 3 20%
Unknown 1 7%
Readers by discipline Count As %
Medicine and Dentistry 11 73%
Biochemistry, Genetics and Molecular Biology 1 7%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Unknown 2 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 May 2018.
All research outputs
#3,780,140
of 12,875,491 outputs
Outputs from Neuropsychiatric Disease and Treatment
#616
of 2,173 outputs
Outputs of similar age
#102,171
of 270,136 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#18
of 79 outputs
Altmetric has tracked 12,875,491 research outputs across all sources so far. This one is in the 49th percentile – i.e., 49% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,173 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 270,136 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 79 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.